1. Home
  2. LIDR vs CLNN Comparison

LIDR vs CLNN Comparison

Compare LIDR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$1.83

Market Cap

69.8M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.03

Market Cap

60.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
CLNN
Founded
2013
2012
Country
United States
United States
Employees
45
79
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
60.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIDR
CLNN
Price
$1.83
$5.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$6.00
$32.67
AVG Volume (30 Days)
4.4M
77.6K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2,510.73
$12.20
Revenue Next Year
$486.88
$20,465.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$2.28
52 Week High
$6.44
$13.50

Technical Indicators

Market Signals
Indicator
LIDR
CLNN
Relative Strength Index (RSI) 49.46 47.40
Support Level $1.80 $3.54
Resistance Level $2.65 $6.83
Average True Range (ATR) 0.27 0.62
MACD -0.02 -0.11
Stochastic Oscillator 25.00 29.26

Price Performance

Historical Comparison
LIDR
CLNN

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: